Filing Flows › Rani Therapeutics Holdings (RANI) › Q1 2026 › vs Q1 2025
Rani Therapeutics Holdings (RANI) Q1 2026 vs Q1 2025 (year over year)
Rani Therapeutics Holdings's revenue rose $1.5M (+893%) from $172K in Q1 2025 to $1.7M in Q1 2026.
Rani Therapeutics Holdings, Q1 2026: revenue $1.7M (+893% year over year), operating margin -488.2%, net loss $8.0M, operating cash flow −$6.5M. The chart draws each line against Q1 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $1.7M | $172K | $1.5M | +893% |
| Other income, net | $324K | −$725K | $1.0M | — |
| Net loss | $8.0M | $12.7M | −$4.7M | -37% |
| Costs & expenses | $10.0M | $12.9M | −$2.9M | -22% |
| Operating costs | $10.0M | $12.2M | −$2.1M | -18% |
| Research & development | $5.2M | $6.6M | −$1.4M | -21% |
| General & admin | $4.9M | $5.6M | −$729K | -13% |
| Operating cash sources | $8.7M | $12.3M | −$3.6M | -29% |
| Depreciation & amortization | $161K | $251K | −$90K | -36% |
| Share-based compensation | $2.1M | $3.9M | −$1.8M | -47% |
| Cash used in operations | $6.5M | $8.1M | −$1.7M | -20% |
| Net loss absorbed | $8.0M | $12.7M | −$4.7M | -37% |
| Working capital & other | $727K | −$413K | $1.1M | — |
Questions
How much did Rani Therapeutics Holdings's revenue grow year over year in Q1 2026?
Rani Therapeutics Holdings's revenue rose $1.5M (+893%) from $172K in Q1 2025 to $1.7M in Q1 2026.